Kidney Injury Molecule-1 and Cardiovascular Diseases: From Basic Science to Clinical Practice

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Medić, Branislava ^a   Rovčanin, Branislav ^a   Basta Jovanović, Gordana ^a   Radojević Škodrić, Sanja ^a   Prostran, Milica ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

KIDNEY INJURY MOLECULE 1; BIOLOGICAL MARKER; HAVCR1 PROTEIN, HUMAN; MEMBRANE PROTEIN; VIRUS RECEPTOR;

ACUTE KIDNEY FAILURE; ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; CARDIORENAL SYNDROME; CARDIOVASCULAR DISEASE; CHEMICAL STRUCTURE; CLINICAL PRACTICE; CRITICALLY ILL PATIENT; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HEART INFARCTION; HEART SURGERY; HUMAN; NONHUMAN; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PREDICTION; REVIEW; SEQUENCE ALIGNMENT; UPREGULATION; ACUTE KIDNEY INJURY; BLOOD; COMPLICATION; PATHOLOGY; PROGNOSIS; URINE;

ACUTE KIDNEY INJURY; BIOMARKERS; CARDIO-RENAL SYNDROME; CARDIOVASCULAR DISEASES; EARLY DIAGNOSIS; HEPATITIS A VIRUS CELLULAR RECEPTOR 1; HUMANS; MEMBRANE GLYCOPROTEINS; PROGNOSIS; RECEPTORS, VIRUS;

EID: 84949843868     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/854070     Document Type: Review

References (93)

1. R. Bellomo, C. Ronco, J. A. Kellum, R. L. Mehta, and P. Palevsky, "Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) group, " Critical Care, vol. 8, pp. R204-R212, 2004.
2. S. Uchino, J. A. Kellum, R. Bellomo et al., "Acute renal failure in critically ill patients: A multinational, multicenter study, " The Journal of the AmericanMedical Association, vol. 294, no. 7, pp. 813-818, 2005.
3. E. A. J. Hoste, G. Clermont, A. Kersten et al., "RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: A cohort analysis, " Critical Care, vol. 10, no. 3, article R73, 2006.
4. T. Z. Ali, I. Khan, W. Simpson et al., "Incidence and outcomes in acute kidney injury: A comprehensive population-based study, " Journal of the American Society of Nephrology, vol. 18, no. 4, pp. 1292-1298, 2007.
5. R. Bellomo, J. A. Kellum, and C. Ronco, "Defining acute renal failure: physiological principles, " Intensive Care Medicine, vol. 30, no. 1, pp. 33-37, 2004.
6. S. G. Coca and C. R. Parikh, "Urinary biomarkers for acute kidney injury: perspectives on translation, " Clinical Journal of the American Society of Nephrology, vol. 3, no. 2, pp. 481-490, 2008.
7. C. L. Dent, Q. Ma, S. Dastrala et al., "Plasma neutrophil gelatinase-Associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: A prospective uncontrolled cohort study, " Critical Care, vol. 11, no. 6, article R127, 2007.
8. J. Atkinson A.J., W. A. Colburn, V. G. DeGruttola et al., "Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework, " Clinical Pharmacology and Therapeutics, vol. 69, no. 3, pp. 89-95, 2001.
9. N. Singhal and A. Saha, "Bedside biomarkers in pediatric cardio renal injuries in emergency, " International Journal of Critical Illness and Injury Science, vol. 4, no. 3, pp. 238-246, 2014.
10. S. S. Soni, C. Ronco, N. Katz, and D. N. Cruz, "Early diagnosis of acute kidney injury: The promise of novel biomarkers, " Blood Purification, vol. 28, no. 3, pp. 165-174, 2009.
11. T. Ichimura, C. C. Hung, S. A. Yang, J. L. Stevens, and J. V. Bonventre, "Kidney injury molecule-1: A tissue and urinary biomarker for nephrotoxicant-induced renal injury, " American Journal of Physiology-Renal Physiology, vol. 286, no. 3, pp. F552-F563, 2004.
12. V. S. Vaidya, V. Ramirez, T. Ichimura, N. A. Bobadilla, and J. V. Bonventre, "Urinary kidney injury molecule-1: A sensitive quantitative biomarker for early detection of kidney tubular injury, " The American Journal of Physiology-Renal Physiology, vol. 290, no. 2, pp. F517-F529, 2006.
13. T. Ichimura, J. V. Bonventre, V. Bailly et al., "Kidney injury molecule-1 (KIM-1) , a putative epithelial cell adhesionmolecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury, " Journal of Biological Chemistry, vol. 273, no. 7, pp. 4135-4142, 1998.
14. T. Ichimura, C. R. Brooks, and J. V. Bonventre, "Kim-1/Tim-1 and immune cells: shifting sands, " Kidney International, vol. 81, no. 9, pp. 809-811, 2012.
15. T. Ichimura, E. J. P. V. Asseldonk, B. D. Humphreys, L. Gunaratnam, J. S. Duffield, and J. V. Bonventre, "Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells, "The Journal of Clinical Investigation, vol. 118, no. 5, pp. 1657-1668, 2008.
16. W. K. Han, V. Bailly, R. Abichandani, R. Thadhani, and J. V. Bonventre, "Kidney Injury Molecule-1 (KIM-1) : A novel biomarker for human renal proximal tubule injury, " Kidney International, vol. 62, no. 1, pp. 237-244, 2002.
17. M. A. Ferguson, V. S. Vaidya, and J. V. Bonventre, "Biomarkers of nephrotoxic acute kidney injury, " Toxicology, vol. 245, no. 3, pp. 182-193, 2008.
18. V. Bailly, Z. Zhang, W. Meier, R. Cate, M. Sanicola, and J. V. Bonventre, "Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration, " The Journal of Biological Chemistry, vol. 277, no. 42, pp. 39739-39748, 2002.
19. P. Devarajan, "The future of pediatric AKI management biomarkers, " Seminars inNephrology, vol. 28, no. 5, pp. 493-498, 2008.
20. H. L. Hillege, D. Nitsch, M. A. Pfeffer et al., "Renal function as a predictor of outcome in a broad spectrum of patients with heart failure, " Circulation, vol. 113, no. 5, pp. 671-678, 2006.
21. D. Feigelstock, P. Thompson, P. Mattoo, Y. Zhang, and G. G. Kaplan, "The human homolog of HAVcr-1 codes for a hepatitis a virus cellular receptor, " Journal of Virology, vol. 72, no. 8, pp. 6621-6628, 1998.
22. M. M. van Timmeren, M. C. van den Heuvel, V. Bailly, S. J. L. Bakker, H. van Goor, and C. A. Stegeman, "Tubular kidney injury molecule-1 (KIM-1) in human renal disease, " The Journal of Pathology, vol. 212, no. 2, pp. 209-217, 2007.
23. J. V. Bonventre, "Kidney injury molecule-1 (KIM-1) : A urinary biomarker and much more, " Nephrology Dialysis Transplantation, vol. 24, no. 11, pp. 3265-3268, 2009.
24. P. Di Tommaso, S. Moretti, I. Xenarios et al., "T-Coffee: A web server for the multiple sequence alignment of protein and RNA sequences using structural information and homology extension, " Nucleic Acids Research, vol. 39, no. 2, pp.W13-W17, 2011.
25. S. F. Altschul, T. L. Madden, A. A. Schäffer et al., "Gapped BLAST and PSI-BLAST: A new generation of protein database search programs, " Nucleic Acids Research, vol. 25, no. 17, pp. 3389-3402, 1997.
26. Z. Todorović, B. Medić, G. Basta-Jovanović et al., "Acute pretreatment with chloroquine attenuates renal I/R injury in rats, " PLoS ONE, vol. 9, no. 3, Article ID e92673, 2014.
27. B.D. Humphreys, V. S. Vaidya, R. Samarakoon, D. M. Hentschel, K. M. Park, and J. V. Bonventre, "Early and sustained expression of kidney injury molecule-1 (Kim-1) after unilateral ureteral obstruction, " Journal of theAmerican Society of Nephrology, vol. 16, p. 425A, 2005.
28. W. C. Prozialeck, V. S. Vaidya, J. Liu et al., "Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity, " Kidney International, vol. 72, no. 8, pp. 985-993, 2007.
29. Y. Zhou, V. S. Vaidya, R. P. Brown et al., "Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium, " Toxicological Sciences, vol. 101, no. 1, pp. 159-170, 2008.
30. J. L. Slocum, M. Heung, and S. Pennathur, "Marking renal injury: can we move beyond serum creatinine?" Translational Research, vol. 159, no. 4, pp. 277-289, 2012.
31. V. S. Sabbisetti, K. Ito, C. Wang, L. Yang, S. C. Mefferd, and J. V. Bonventre, "Novel assays for detection of urinary KIM-1 in mouse models of kidney injury, " Toxicological Sciences, vol. 131, no. 1, pp. 13-25, 2013.
32. A. B. Kramer, M. M. van Timmeren, T. A. Schuurs et al., "Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over time, " American Journal of Physiology-Renal Physiology, vol. 296, no. 5, pp. F1136-F1145, 2009.
33. J. Martensson, C.-R. Martling, and M. Bell, "Novel biomarkers of acute kidney injury and failure: clinical applicability, " British Journal of Anaesthesia, vol. 109, no. 6, pp. 843-850, 2012.
34. F. Dieterle, F. Sistare, F. Goodsaid et al., "Renal biomarker qualification submission: A dialog between the FDA-EMEA and Predictive Safety Testing Consortium, " Nature Biotechnology, vol. 28, no. 5, pp. 455-462, 2010.
35. O. Liangos, M. C. Perianayagam, V. S. Vaidya et al., "Urinary N-Acetyl-β (D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure, " Journal of theAmerican Society of Nephrology, vol. 18, no. 3, pp. 904-912, 2007.
36. S. G. Coca, R. Yalavarthy, J. Concato, and C. R. Parikh, "Biomarkers for the diagnosis and risk stratification of acute kidney injury: A systematic review, " Kidney International, vol. 73, no. 9, pp. 1008-1016, 2008.
37. V. S. Vaidya, G. M. Ford, S. S. Waikar et al., "A rapid urine test for early detection of kidney injury, " Kidney International, vol. 76, no. 1, pp. 108-114, 2009.
38. Z. Todorović, M. Prostran, Z. Nesić, R. Stojanović, and M. Stojanov, "The influence of drugs on biochemical markers of ischemia-reperfusion injury, " in The Analysis of Pharmacologically Active Compounds and Biomolecules in Real Samples, R. Injac, Ed., pp. 217-238, Transworld Research Network, Kerala, India, 2009.
39. E. Tsigou, V. Psallida, C. Demponeras, E. Boutzouka, and G. Baltopoulos, "Role of newbiomarkers: functional and structural damage, " Critical Care Research and Practice, vol. 2013, Article ID361078, 13 pages, 2013.
40. G. Lucarelli, V. Mancini, V. Galleggiante et al., "Emerging urinary markers of renal injury in obstructive nephropathy, " BioMed Research International, vol. 2014, Article ID 303298, 7 pages, 2014.
41. G. Lucarelli, P. Ditonno, C. Bettocchi et al., "Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma, " DiseaseMarkers, vol. 2014, Article ID689795, 9 pages, 2014.
42. S. R. Lee and K. H. Jeong, "Novel biomarkers for cardio-renal syndrome, " Electrolyte and Blood Pressure, vol. 10, no. 1, pp. 12-17, 2012.
43. D. Aronson, "Cardiorenal syndrome in acute decompensated heart failure, " Expert Review of CardiovascularTherapy, vol. 10, no. 2, pp. 177-189, 2012.
44. S. S. Gottlieb, W. Abraham, J. Butler et al., "The prognostic importance of different definitions of worsening renal function in congestive heart failure, " Journal of Cardiac Failure, vol. 8, no. 3, pp. 136-141, 2002.
45. D. E. Forman, J. Butler, Y. Wang et al., "Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure, " Journal of the American College of Cardiology, vol. 43, no. 1, pp. 61-67, 2004.
46. National Kidney Foundation, "K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, " American Journal of Kidney Diseases, vol. 39, pp. S1-S266, 2002.
47. J. T. Heywood, G. C. Fonarow, M. R. Costanzo, V. S. Mathur, J. R. Wigneswaran, and J. Wynne, "High prevalence of renal dysfunction and its impact on outcome in 118, 465 patients hospitalized with acute decompensated heart failure: A report fromthe ADHERE database, " Journal of Cardiac Failure, vol. 13, no. 6, pp. 422-430, 2007.
48. M. Tonelli, N. Wiebe, B. Culleton et al., "Chronic kidney disease andmortality risk: A systematic review, " Journal of the American Society of Nephrology, vol. 17, no. 7, pp. 2034-2047, 2006.
49. R. Hawkins, "New biomarkers of acute kidney injury and the cardio-renal syndrome, " Korean Journal of LaboratoryMedicine, vol. 31, no. 2, pp. 72-80, 2011.
50. K. Damman, S. Masson, H. L. Hillege et al., "Clinical outcome of renal tubular damage in chronic heart failure, " European Heart Journal, vol. 32, no. 21, pp. 2705-2712, 2011.
51. R. Ghatanatti, A. Teli, S. S. Tirkey, S. Bhattacharya, G. Sengupta, and A. Mondal, "Role of renal biomarkers as predictors of acute kidney injury in cardiac surgery, " Asian Cardiovascular and Thoracic Annals, vol. 22, no. 2, pp. 234-241, 2014.
52. R. Bellomo, S. Auriemma, A. Fabbri et al., "Thepathophysiology of cardiac surgery-Associated acute kidney injury (CSA-AKI) , " International Journal of Artificial Organs, vol. 31, no. 2, pp. 166-178, 2008.
53. K. Karkouti, D. N. Wijeysundera, T.M. Yau et al., "Acute kidney injury after cardiac surgery: focus on modifiable risk factors, " Circulation, vol. 119, no. 4, pp. 495-502, 2009.
54. A. Lassnigg, D. Schmidlin, M. Mouhieddine et al., "Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: A prospective cohort study, " Journal of the American Society of Nephrology, vol. 15, no. 6, pp. 1597-1605, 2004.
55. H. Mao, N. Katz, W. Ariyanon et al., "Cardiac surgeryassociated acute kidney injury, " CardioRenal Medicine, vol. 3, no. 3, pp. 178-199, 2013.
56. M. Haase, R. Bellomo, and A. Haase-Fielitz, "Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-Associated acute kidney injury, " Journal of the American College of Cardiology, vol. 55, no. 19, pp. 2024-2033, 2010.
57. H. Kolli, S. Rajagopalam, N. Patel et al., "Mild acute kidney injury is associated with increased mortality after cardiac surgery in patients with eGFR 60 mL/min/1.73 m2" Renal Failure 32 9 1066-1072 2011
58. J. Mishra, C. Dent, R. Tarabishi et al., "Neutrophil gelatinaseassociated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery, " The Lancet, vol. 365, no. 9466, pp. 1231-1238, 2005.
59. O. Liangos, W. K. Han, R. Wald et al., "Urinary kidney injury molecule-1 level is an early and sensitive marker of acute kidney injury [Abstract], " Journal of the American Society of Nephrology, vol. 17, p. 403A, 2006.
60. W. K. Han, S. S. Waikar, A. Johnson, G. C. Curhan, P. Devarajan, and J. V. Bonventre, "Urinary biomarkers for early detection of acute kidney injury [Abstract], " Journal of the American Society of Nephrology, vol. 17, article 403A, 2006.
61. C. Hudson, J. Hudson, M. Swaminathan, A. Shaw, M. Stafford-Smith, and U. D. Patel, "Emerging concepts in acute kidney injury following cardiac surgery, " Seminars in Cardiothoracic and Vascular Anesthesia, vol. 12, no. 4, pp. 320-330, 2008.
62. J. L. Koyner, V. S. Vaidya, M. R. Bennett et al., "Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury, " Clinical Journal of the American Society of Nephrology, vol. 5, no. 12, pp. 2154-2165, 2010.
63. I. E. Hall, S. G. Coca, M. A. Perazella et al., "Risk of poor outcomes with novel and traditional biomarkers at clinical AKI diagnosis, " Clinical Journal of the American Society of Nephrology, vol. 6, no. 12, pp. 2740-2749, 2011.
64. J.M. Arthur, E. G. Hill, J. L. Alge et al., "Evaluation of 32 urine biomarkers to predict the progression of acute kidney injury after cardiac surgery, " Kidney International, vol. 85, no. 2, pp. 431-438, 2014.
65. W. K. Han, G. Wagener, Y. Zhu, S. Wang, and H. T. Lee, "Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery, " Clinical Journal of the American Society of Nephrology, vol. 4, no. 5, pp. 873-882, 2009.
66. E. Abdallah, E. Waked, B. Al-Helal, R. Asad, M. Nabil, and T. Harba, "Novel troponin-like biomarkers of acute kidney injury, " Saudi Journal of Kidney Diseases and Transplantation, vol. 24, no. 6, pp. 1111-1124, 2013.
67. W. K. Han, S. S. Waikar, A. Johnson et al., "Urinary biomarkers in the early diagnosis of acute kidney injury, " Kidney International, vol. 73, no. 7, pp. 863-869, 2008.
68. C. D. Krawczeski, J. G. Woo, Y. Wang, M. R. Bennett, Q. Ma, and P. Devarajan, "Neutrophil gelatinase-Associated lipocalin concentrations predict development of acute kidney injury in neonates and children after cardiopulmonary bypass, " The Journal of Pediatrics, vol. 158, no. 6, pp. 1009.e1-1015.e1, 2011.
69. M. A. Hazle, R. J. Gajarski, R. Aiyagari et al., "Urinary biomarkers and renal near-infrared spectroscopy predict intensive care unit outcomes after cardiac surgery in infants younger than 6 months of age, " Journal ofThoracic and Cardiovascular Surgery, vol. 146, no. 4, pp. 861.e1-867.e1, 2013.
70. H. L. Hillege, W. H. van Gilst, D. J. van Veldhuisen et al., "Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: The CATS randomized trial, " European Heart Journal, vol. 24, no. 5, pp. 412-420, 2003.
71. C. R. Parikh, S. G. Coca, Y. Wang, F. A. Masoudi, and H. M. Krumholz, "Long-Term prognosis of acute kidney injury after acute myocardial infarction, " Archives of Internal Medicine, vol. 168, no. 9, pp. 987-995, 2008.
72. A. Goldberg, E. Kogan, H. Hammerman, W. Markiewicz, and D. Aronson, "The impact of transient and persistent acute kidney injury on long-Term outcomes after acute myocardial infarction, " Kidney International, vol. 76, no. 8, pp. 900-906, 2009.
73. A. A. Eddy, "Molecular basis of renal fibrosis, " PediatricNephrology, vol. 15, no. 3-4, pp. 290-301, 2000.
74. N. G. Frangogiannis, "The immune system and cardiac repair, " Pharmacological Research, vol. 58, no. 2, pp. 88-111, 2008.
75. M. Nian, P. Lee, N. Khaper, and P. Liu, "Inflammatory cytokines and postmyocardial infarction remodeling, " Circulation Research, vol. 94, no. 12, pp. 1543-1553, 2004.
76. H. J. Dargie, H. M. McAlpine, and J. J. Morton, "Neuroendocrine activation in acute myocardial infarction, " Journal of Cardiovascular Pharmacology, vol. 9, no. 2, pp. S21-S24, 1987.
77. D. Fraccarollo, P. Galuppo, S. Hildemann, M. Christ, G. Ertl, and J. Bauersachs, "Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction, " Journal of the American College of Cardiology, vol. 42, no. 9, pp. 1666-1673, 2003.
78. L. McDonald, C. Baker, C. Bray, A. McDonald, and N. Restieaux, "Plasma-catecholamines after cardiac infarction, " The Lancet, vol. 2, no. 7629, pp. 1021-1023, 1969.
79. H. Persson, K. Andrasson, T. Kahan et al., "Neurohormonal activation in heart failure after acute myocardial infarction treated with beta-receptor antagonists, " European Journal of Heart Failure, vol. 4, no. 1, pp. 73-82, 2002.
80. S. Lekawanvijit, A. R. Kompa, Y. Zhang, B. H. Wang, D. J. Kelly, and H. Krum, "Myocardial infarction impairs renal function, induces renal interstitial fibrosis, and increases renal KIM-1 expression: implications for cardiorenal syndrome, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 302, no. 9, pp. H1884-H1893, 2012.
81. A. Halawa, "Theearly diagnosis of acute renal graft dysfunction: A challenge we face. The role of novel biomarkers, " Annals of Transplantation, vol. 16, no. 1, pp. 90-98, 2011.
82. D. N. Cruz, H. R. de Geus, and S. M. Bagshaw, "Biomarker strategies to predict need for renal replacement therapy in acute kidney injury, " Seminars in Dialysis, vol. 24, no. 2, pp. 124-131, 2011.
83. W. N. Nijboer, T. A. Schuurs, J. Damman et al., "Kidney injury molecule-1 is an early noninvasive indicator for donor brain death-induced injury prior to kidney transplantation, " American Journal of Transplantation, vol. 9, no. 8, pp. 1752-1759, 2009.
84. B. Schröppel, B. Krüger, L. Walsh et al., "Tubular expression of KIM-1 does not predict delayed function after transplantation, " Journal of the American Society of Nephrology, vol. 21, no. 3, pp. 536-542, 2010.
85. C.-C. Szeto, B. C.-H. Kwan, K.-B. Lai et al., "Urinary expression of kidney injury markers in renal transplant recipients, " Clinical Journal of the American Society of Nephrology, vol. 5, no. 12, pp. 2329-2337, 2010.
86. P.W. Peake, T. J. Pianta, L. Succar et al., "A comparison of the ability of levels of urinary biomarker proteins and exosomal mRNA to predict outcomes after renal transplantation, " PLoS ONE, vol. 9, no. 6, Article ID e98644, 2014.
87. T. J. Pianta, P. W. Peake, J. W. Pickering, M. Kelleher, N. A. Buckley, and Z. H. Endre, "Clusterin in kidney transplantation: novel biomarkers versus serumcreatinine for early prediction of delayed graft function, " Transplantation, vol. 99, no. 1, pp. 171-179, 2015.
88. U. Kunzendorf, M. Haase, L. Rölver, and A. Haase-Fielitz, "Novel aspects of pharmacological therapies for acute renal failure, " Drugs, vol. 70, no. 9, pp. 1099-1114, 2010.
89. S. Kokkoris, C. Pipili, E. Grapsa, T. Kyprianou, and S. Nanas, "Novel biomarkers of acute kidney injury in the general adult ICU: A review, " Renal Failure, vol. 35, no. 4, pp. 579-591, 2013.
90. F. Gonzalez and F. Vincent, "Biomarkers for acute kidney injury in critically ill patients, "Minerva Anestesiologica, vol. 78, no. 12, pp. 1394-1403, 2012.
91. Z. H. Endre, J. W. Pickering, R. J. Walker et al., "Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function, " Kidney International, vol. 79, no. 10, pp. 1119-1130, 2011.
92. G. L. Smith, J. H. Lichtman, M. B. Bracken et al., "Renal impairment and outcomes in heart failure: systematic review and meta-Analysis, " Journal of the American College of Cardiology, vol. 47, no. 10, pp. 1987-1996, 2006.
93. Z. H. Endre and J.W. Pickering, "Biomarkers and creatinine in AKI: The trough of disillusionment or the slope of enlightenment?" Kidney International, vol. 84, no. 4, pp. 644-647, 2013.